Legal & General Group Plc Makes New Investment in National Health Investors, Inc. $NHI

Key Points

• Legal & General Group Plc purchased 285,144 shares of National Health Investors in the second quarter, valued at approximately $21.7 million and representing a 0.58% stake. Institutional investors collectively own 62.51% of NHI.
• NHI insiders also bought shares: CEO D. Eric Mendelsohn purchased 1,500 shares, while Director Robert A. McCabe Jr. bought 890 shares. Company insiders own 2.70% of the stock.
• NHI reported quarterly EPS of $1.19 on revenue of $121.32 million and maintained 2026 EPS guidance of $4.74–$4.79. The company declared a $0.92 quarterly dividend, yielding about 5.1%, while analysts maintain a “Moderate Buy” consensus with an average $83.86 price target.

Legal & General Group Plc purchased a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 285,144 shares of the real estate investment trust's stock, valued at approximately $21,745,000. Legal & General Group Plc owned 0.58% of National Health Investors as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Renaissance Group LLC increased its stake in shares of National Health Investors by 3.8% in the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust's stock valued at $245,000 after acquiring an additional 117 shares in the last quarter. Captrust Financial Advisors boosted its stake in National Health Investors by 1.7% during the fourth quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust's stock worth $680,000 after acquiring an additional 146 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in National Health Investors by 34.3% in the first quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock worth $51,000 after purchasing an additional 160 shares during the period. Assetmark Inc. grew its holdings in National Health Investors by 13.5% in the first quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust's stock worth $110,000 after purchasing an additional 161 shares during the period. Finally, Inspire Investing LLC increased its stake in National Health Investors by 3.2% in the first quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust's stock valued at $510,000 after purchasing an additional 198 shares in the last quarter. 62.51% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO D. Eric Mendelsohn bought 1,500 shares of the company's stock in a transaction dated Friday, June 5th. The shares were bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer directly owned 133,316 shares of the company's stock, valued at $9,177,473.44. This trade represents a 1.14% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert A. Mccabe, Jr. bought 890 shares of the business's stock in a transaction that occurred on Monday, June 15th. The shares were bought at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director owned 44,159 shares of the company's stock, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 2.70% of the stock is owned by company insiders.

National Health Investors Stock Down 0.8%

Shares of NYSE NHI opened at $71.96 on Friday. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The company has a 50-day moving average price of $75.68 and a 200-day moving average price of $78.76. The stock has a market capitalization of $3.53 billion, a P/E ratio of 20.80, a P/E/G ratio of 3.83 and a beta of 0.51. National Health Investors, Inc. has a 1 year low of $67.94 and a 1 year high of $91.38.

National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The company's revenue was up 1.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities research analysts forecast that National Health Investors, Inc. will post 4.78 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 5.1%. National Health Investors's dividend payout ratio is 108.67%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on NHI shares. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a report on Thursday, June 25th. BMO Capital Markets decreased their target price on National Health Investors from $90.00 to $80.00 and set an "outperform" rating for the company in a research report on Monday, June 15th. Wells Fargo & Company dropped their price target on National Health Investors from $84.00 to $79.00 and set an "equal weight" rating on the stock in a research note on Monday, June 1st. Weiss Ratings cut National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research note on Friday, June 12th. Finally, Zacks Research downgraded National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $83.86.

National Health Investors Company Profile

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source